Free Trial

Vertex Pharmaceuticals (VRTX) Competitors

Vertex Pharmaceuticals logo
$396.62 -4.38 (-1.09%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$396.83 +0.21 (+0.05%)
As of 09/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRTX vs. AMZN, AXSM, CRSP, EDIT, GOOG, ISRG, MRNA, ABBV, LLY, and PFE

Should you be buying Vertex Pharmaceuticals stock or one of its competitors? The main competitors of Vertex Pharmaceuticals include Amazon.com (AMZN), Axsome Therapeutics (AXSM), CRISPR Therapeutics (CRSP), Editas Medicine (EDIT), Alphabet (GOOG), Intuitive Surgical (ISRG), Moderna (MRNA), AbbVie (ABBV), Eli Lilly and Company (LLY), and Pfizer (PFE).

Vertex Pharmaceuticals vs. Its Competitors

Vertex Pharmaceuticals (NASDAQ:VRTX) and Amazon.com (NASDAQ:AMZN) are related large-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Vertex Pharmaceuticals has a net margin of 31.86% compared to Amazon.com's net margin of 10.54%. Vertex Pharmaceuticals' return on equity of 23.91% beat Amazon.com's return on equity.

Company Net Margins Return on Equity Return on Assets
Vertex Pharmaceuticals31.86% 23.91% 17.14%
Amazon.com 10.54%23.84%11.14%

Vertex Pharmaceuticals has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Amazon.com has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.

91.0% of Vertex Pharmaceuticals shares are owned by institutional investors. Comparatively, 72.2% of Amazon.com shares are owned by institutional investors. 0.2% of Vertex Pharmaceuticals shares are owned by company insiders. Comparatively, 10.8% of Amazon.com shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Amazon.com has higher revenue and earnings than Vertex Pharmaceuticals. Vertex Pharmaceuticals is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vertex Pharmaceuticals$11.02B9.23-$535.60M$13.9928.35
Amazon.com$637.96B3.78$59.25B$6.5634.45

Vertex Pharmaceuticals currently has a consensus target price of $497.10, indicating a potential upside of 25.33%. Amazon.com has a consensus target price of $262.87, indicating a potential upside of 16.32%. Given Vertex Pharmaceuticals' higher possible upside, equities analysts clearly believe Vertex Pharmaceuticals is more favorable than Amazon.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vertex Pharmaceuticals
0 Sell rating(s)
13 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.56
Amazon.com
0 Sell rating(s)
2 Hold rating(s)
46 Buy rating(s)
2 Strong Buy rating(s)
3.00

In the previous week, Amazon.com had 206 more articles in the media than Vertex Pharmaceuticals. MarketBeat recorded 239 mentions for Amazon.com and 33 mentions for Vertex Pharmaceuticals. Vertex Pharmaceuticals' average media sentiment score of 1.46 beat Amazon.com's score of 1.06 indicating that Vertex Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vertex Pharmaceuticals
30 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Amazon.com
177 Very Positive mention(s)
17 Positive mention(s)
23 Neutral mention(s)
18 Negative mention(s)
4 Very Negative mention(s)
Positive

Summary

Amazon.com beats Vertex Pharmaceuticals on 9 of the 17 factors compared between the two stocks.

Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRTX vs. The Competition

MetricVertex PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$100.25B$3.11B$5.77B$9.76B
Dividend YieldN/A2.28%6.66%4.49%
P/E Ratio28.3521.1082.3726.60
Price / Sales9.23371.03525.77170.66
Price / CashN/A43.5325.7028.92
Price / Book5.928.1310.646.56
Net Income-$535.60M-$53.35M$3.28B$266.04M
7 Day Performance1.17%0.73%0.09%-0.89%
1 Month Performance-16.02%7.76%8.90%4.34%
1 Year Performance-17.12%11.97%48.37%24.06%

Vertex Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRTX
Vertex Pharmaceuticals
4.982 of 5 stars
$396.62
-1.1%
$497.10
+25.3%
-16.6%$100.25B$11.02B28.356,100Positive News
Analyst Forecast
AMZN
Amazon.com
4.7886 of 5 stars
$227.94
-0.4%
$262.87
+15.3%
+28.2%$2.43T$637.96B34.751,556,000Trending News
AXSM
Axsome Therapeutics
4.7627 of 5 stars
$116.31
-1.9%
$178.00
+53.0%
+36.1%$5.80B$495.03M-22.94380Positive News
Analyst Forecast
Insider Trade
CRSP
CRISPR Therapeutics
3.5926 of 5 stars
$54.13
-0.3%
$71.60
+32.3%
+16.4%$4.92B$35M-9.97460Analyst Revision
EDIT
Editas Medicine
4.0267 of 5 stars
$2.72
-2.9%
$5.10
+87.5%
-28.4%$244.58M$38.90M-0.95230News Coverage
Analyst Forecast
Gap Up
GOOG
Alphabet
4.5612 of 5 stars
$209.16
+1.2%
$215.19
+2.9%
+45.7%$2.53T$371.40B22.27190,200Trending News
Analyst Forecast
Gap Up
ISRG
Intuitive Surgical
4.9567 of 5 stars
$468.44
-1.6%
$595.95
+27.2%
-8.7%$167.93B$8.35B65.3315,638Positive News
Insider Trade
MRNA
Moderna
4.5519 of 5 stars
$25.35
-6.5%
$42.88
+69.2%
-67.0%$9.86B$3.24B-3.375,800
ABBV
AbbVie
4.6298 of 5 stars
$207.58
-1.4%
$214.95
+3.6%
+7.1%$366.70B$58.33B98.8555,000Trending News
LLY
Eli Lilly and Company
5 of 5 stars
$696.08
-2.2%
$950.17
+36.5%
-23.0%$658.81B$45.04B45.5047,000Trending News
Analyst Revision
PFE
Pfizer
4.8441 of 5 stars
$25.15
-2.8%
$28.12
+11.8%
-12.5%$142.99B$63.63B13.3881,000Trending News

Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners